IND Enabling Studies for a Novel Mas Receptor Agonist for Treatment of Cognitive Impairment in Patients at Risk for Alzheimer's Disease Related Dementia Grant

IND Enabling Studies for a Novel Mas Receptor Agonist for Treatment of Cognitive Impairment in Patients at Risk for Alzheimer's Disease Related Dementia .

date/time interval

  • February 5, 2022 - March 31, 2023

awarded by

subcontracted through

administered by

sponsor award ID

  • 648884 | 3U01AG066623-03S1
  • 648884 | 5U01AG066623-04

contributor